Request for Public Comment on the Updated Criteria for Determining Maternity Care Health Professional Target Areas
Published Date: 2/3/2026
Notice
Summary
HRSA is updating how it picks areas that really need maternity care pros by dropping the Social Vulnerability Index and giving more points to how many moms need care and how far they must travel. This change affects communities with maternity care shortages and helps decide where to send health workers. If you’ve got thoughts, speak up by March 5, 2026—this could shape where money and help go next!
Analyzed Economic Effects
2 provisions identified: 0 benefits, 0 costs, 2 mixed.
SVI Removed; Points Reallocated to Shortage and Travel
HRSA is removing the Social Vulnerability Index (SVI) criterion (previously worth 0–2 points) from the maternity care target area (MCTA) score and is reallocating those two points: one point to the population-to-full-time-equivalent maternity care health professional ratio and one point to travel distance/time to the nearest accessible care. HRSA says there were over 7,600 MCTAs as of September 2025, the composite MCTA score range is 0–25, and redistributing the SVI points would raise average MCTA scores by 6.6% overall while about 200 MCTAs may see a score decrease (largely those designated for Medicaid-eligible populations and certain low-income migrant populations).
Change May Affect NHSC Loan Repayment Awards
HRSA primarily uses MCTA scores to help distribute National Health Service Corps (NHSC) loan repayment awards to eligible maternity care health professionals. HRSA notes providers can apply using either the primary care HPSA score or the MCTA score of their site, whichever is higher, so some providers in areas with lower MCTA scores after this change may instead rely on their primary care HPSA score.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16396, National Newborn Screening Stakeholder Workgroup
HRSA provides funding to support a national center for newborn screening systems known as the National Center for Newborn Screening Systems Excellence (NBS Excel). In fiscal year 2026, supplemental funding is being provided to NBS Excel to establish a national newborn screening stakeholder workgroup. This workgroup will be a pathway for conditions to be considered and recommended for inclusion in the Recommended Uniform Screening Panel (RUSP) and to discuss national- level issues related to newborn screening. Membership will include representatives from a wide range of newborn screening experts and stakeholders. The award recipient will convene the workgroup and develop findings, reports, and recommendations for HRSA's review and consideration. HRSA will then make recommendations to the Secretary of Health and Human Services, who has final decision-making authority on updates to the RUSP.
2026-16227, Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Transforming Pediatrics for Early Childhood Program Performance Measures
In compliance with the Paperwork Reduction Act of 1995, HRSA submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. OMB may act on HRSA's ICR only after the 30-day comment period for this notice has closed.
2026-16054, Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Organ Procurement and Transplantation Network Board of Directors and Committee Member Applications and Forms
In compliance with the requirement for opportunity for public comment on proposed data collection projects of the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR.
2026-15596, Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; National Health Service Corps Scholar/Students to Service Travel Worksheet, OMB No. 0906-0087-Revision
In compliance with the Paperwork Reduction Act of 1995, HRSA submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. OMB may act on HRSA's ICR only after the 30-day comment period for this notice has closed.
2026-15633, Notice Regarding 340B Rebate Model Pilot Program
The U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA), Office of Pharmacy Affairs (OPA), which administers the 340B Drug Pricing Program (340B Program), is issuing this Notice to announce the availability of a revised 340B Rebate Model Pilot Program (Pilot). The Pilot provides a rebate mechanism through which qualifying drug manufacturers may effectuate the 340B ceiling price for certain drugs sold to covered entities. Consistent with HRSA's longstanding statutory authority, rebates will be used instead of upfront discounts. HRSA issued a Request for Information (RFI) \1\ to gather input from interested parties regarding the potential use of rebates to effectuate the ceiling price under the 340B Program, including the standards and procedures that should govern the approval of manufacturer rebate plans and the impacts on all stakeholders. After carefully considering all comments from interested parties and different policy alternatives, HRSA is announcing this Pilot, which will implement a rebate approach for a limited set of drugs, and which builds on established and successful rebate programs. ---------------------------------------------------------------------------
2026-15221, Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Applicant Organizational National Provider Identifiers and Centers for Medicare & Medicaid Services Certification Numbers Form
In compliance with the requirement for opportunity for public comment on proposed data collection projects of the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR.
Previous / Next Documents
Previous: 2026-02129, Patient Safety Organizations: Voluntary Relinquishment for the VizientTM PSO
Vizient™ PSO has decided to give up its official status as a Patient Safety Organization, and the government has accepted this change as of January 7, 2026. This affects healthcare providers who rely on Vizient™ PSO for patient safety data and support. No money changes hands, but providers should check updated PSO listings to stay in the know.
Next: 2026-02132, Holtec Decommissioning International, LLC, Holtec Palisades, LLC, and Holtec Big Rock Point, LLC; Big Rock Point; Consideration of Approval of Transfer of License and Conforming Amendment
Holtec wants to switch who officially owns the Big Rock Point nuclear site, moving the license from Holtec Palisades, LLC to Holtec Big Rock Point, LLC, while Holtec Decommissioning International stays in charge of running it. The Nuclear Regulatory Commission is reviewing this change and asking the public to share their thoughts or request a hearing by late February or early March 2026. This move is mostly an ownership shuffle with no big money or timing changes announced yet.